Search results - 1 result

Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.

included in the analysis. The successful outcome and mortality rates were respectively 83.3% and 11.1%. No relapses were observed in cured patients after a median follow-up of 4 years. No specific adverse ...

QR code

QR code for this page URL